Compare Nokia Corp (NOK) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs Novavax Inc — how do they compare? Nokia Corp trades at $10.98 (market cap $56.70B), while Novavax Inc trades at $8.06 (market cap $1.30B). The key difference: Nokia Corp is far larger — about 43.6× Novavax Inc's market cap, and Nokia Corp pays a 1.63% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NOK | NVAX | |
|---|---|---|
Market Cap | $56.70B | $1.30B |
Sector | Technology | Health |
52-Week High | $16.83 | $11.19 |
52-Week Low | $4.05 | $6.22 |
Enterprise Value | $53.51B | $800.50M |
Dividend Yield | 1.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
